There are currently 4 active clinical trials seeking participants for AIDS research studies. The states with the highest number of trials for AIDS participants are California, Florida, District of Columbia and Texas.
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
NCT03670316
Recruiting
To determine the efficacy of an algorithm designed to recommend smoking cessation-related pharmacotherapy options to the primary care providers of smokers living with HIV/AIDS.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/06/2024
Locations: University of Alabama, Birmingham, Birmingham, Alabama
Conditions: HIV, AIDS, Smoking Cessation
Register for Updates
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
NCT06202898
Recruiting
The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.
Gender:
Male
Ages:
18 years and above
Trial Updated:
04/11/2024
Locations: University of Central Florida, Orlando, Florida
Conditions: Transgender Women, Aids, Hiv
Register for Updates
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
NCT01206920
Recruiting
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for outpatients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in Washington, DC.
Gender:
All
Ages:
All
Trial Updated:
10/27/2023
Locations: Kaiser Permanente Mid-Atlantic States, Washington, District of Columbia +13 locations
Conditions: HIV, AIDS
Register for Updates
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
NCT06045923
Recruiting
The purpose of this study is to examine the extent of mpox viral spread and immunologic markers in people with advanced HIV. Study findings will enhance knowledge of mpox pathogenesis in severely immunocompromised people, which can inform treatment and prevention of severe illness and deaths associated with mpox in people with advanced HIV.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/18/2023
Locations: Centers for Disease Control and Prevention, Atlanta, Georgia
Conditions: Monkeypox, HIV Infections, AIDS
Register for Updates